- Home
- BMRN vs ONTO Comparison
BMRN vs ONTO Comparison
Compare BMRN & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | ONTO |
|---|---|---|
| Founded | 1996 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 9.4B |
| IPO Year | 1999 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BMRN | ONTO |
|---|---|---|
| Price | $56.55 | $269.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 8 |
| Target Price | $88.22 | ★ $290.63 |
| AVG Volume (30 Days) | ★ 2.3M | 1.1M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.54 | ★ 0.67 |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $26.63 |
| Revenue Next Year | $12.23 | $16.26 |
| P/E Ratio | ★ $105.13 | $377.97 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $89.40 |
| 52 Week High | $66.28 | $316.00 |
Technical Indicators
Market Signals| Indicator | BMRN | ONTO |
|---|---|---|
| Relative Strength Index (RSI) | 57.06 | 50.83 |
| Support Level | $51.74 | $181.69 |
| Resistance Level | $56.91 | $312.85 |
| Average True Range (ATR) | 1.74 | 13.61 |
| MACD | 0.52 | -0.46 |
| Stochastic Oscillator | 84.40 | 68.11 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.